Literature DB >> 27149982

Doctors should be able to prescribe exercise like a drug.

David Nunan1.   

Abstract

Mesh：

Year:  2016        PMID： 27149982     DOI： 10.1136/bmj.i2468

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Effect of Promotional Initiatives on Visits to a Dedicated Website for Physical Activity and Non-Communicable Disease in Luxembourg: An Event Study.

Authors:  Alexis Lion; Jane S Thornton; Michel Vaillant; Juliette Pertuy; Eric Besenius; Cyrille Hardy; Charles Delagardelle; Romain Seil; Axel Urhausen; Daniel Theisen
Journal:  Front Public Health       Date:  2017-05-29

2.  An education programme influencing health professionals to recommend exercise to their type 2 diabetes patients - understanding the processes: a case study from Oxfordshire, UK.

Authors:  Anne Matthews; Natasha Jones; Alastair Thomas; Perdy van den Berg; Charlie Foster
Journal:  BMC Health Serv Res       Date:  2017-02-11       Impact factor: 2.655

3.  A higher effort-based paradigm in physical activity and exercise for public health: making the case for a greater emphasis on resistance training.

Authors:  James Steele; James Fisher; Martin Skivington; Chris Dunn; Josh Arnold; Garry Tew; Alan M Batterham; David Nunan; Jamie M O'Driscoll; Steven Mann; Chris Beedie; Simon Jobson; Dave Smith; Andrew Vigotsky; Stuart Phillips; Paul Estabrooks; Richard Winett
Journal:  BMC Public Health       Date:  2017-04-05       Impact factor: 3.295

4.  Patient and Healthcare Professionals Perspectives on the Delivery of Exercise Education for Patients With Type 1 Diabetes.

Authors:  Ian Litchfield; Rob C Andrews; Parth Narendran; Sheila Greenfield
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-19       Impact factor: 5.555

5.  Changes in the mode of travel to work and the severity of depressive symptoms: a longitudinal analysis of UK Biobank.

Authors:  Craig S Knott; Jenna Panter; Louise Foley; David Ogilvie
Journal:  Prev Med       Date:  2018-03-28       Impact factor: 4.018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.